The world has changed since Sanofi in February unveiled its intention to spin off its API production operations in Europe, but the company is still pressing ahead with the split, sources told Reuters. Sanofi will start prepping this fall for a stock market listing of the new company by 2022 and is discussing the business with potential investors, including France’s… Read More »
As questions swirl over equitable access to COVID-19 vaccines, Sanofi CEO Paul Hudson has laid out some of his company’s plans should its program succeed, Bloomberg reports. A key point? The U.S. will be first in line. The U.S. stepped up first to invest in the company’s research, Hudson told the news service, so it “has… Read More »
Sanofi said Wednesday it will sell monthly supplies of insulin for a fixed price of $ 99 for patients paying with cash in the U.S. as the pharmaceutical giant faces intense pressure from the Trump administration and Congress to lower the cost of its nearly 100-year-old, life-saving medication.